Literature DB >> 26225192

Is gall bladder cancer a bad cancer per se?

Vinay K Kapoor1.   

Abstract

Gall bladder cancer (GBC) has one of the poorest outcomes of all cancers. Early GBC is difficult to diagnose on even computed tomography. GB has no submucosa and the cancer infiltrates directly into the muscularis propria. GB wall is thin and important adjacent organs viz. liver, duodenum and pancreas get easily infiltrated. Tumor in the GB neck often needs extended right hepatectomy. Infiltration of duodenum/pancreas may necessitate pancreato-duodenectomy or even hepato-pancreato-duodenectomy. Mortality of surgical procedures, when performed for GBC, is higher than when performed for other cancers. Survival in GBC, even after R0 resection, is poor. There is no proven role of neo-adjuvant or adjuvant therapy for loco-regionally advanced GBC. There is no role of palliative surgery in metastatic GBC. Early GBC is diagnosed incidentally after cholecystectomy for stones and requires reoperation for completion extended cholecystectomy but unfortunately, most surgeons are not aware of this. GBC has a peculiar epidemiology and is uncommon in the West and has, therefore, not received much attention. Preventive cholecystectomy for asymptomatic stones is not recommended and there is no serum marker for screening. With all factors pitched against it, it does appear that GBC is a bad cancer per se!

Entities:  

Keywords:  Cholangiocarcinoma; Cholecystectomy; Gall bladder neoplasms; Hepatectomy; Hepato-pancreato-duodenectomy

Year:  2015        PMID: 26225192      PMCID: PMC4513432          DOI: 10.4240/wjgs.v7.i7.107

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  5 in total

Review 1.  Incidental gall bladder cancer.

Authors:  Anu Behari; Vinay K Kapoor
Journal:  Adv Surg       Date:  2013

2.  Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations.

Authors:  Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Yu Takahashi; Masato Nagino
Journal:  Dig Surg       Date:  2012-03-15       Impact factor: 2.588

3.  Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients.

Authors:  Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Yu Takahashi; Yuji Nimura; Masato Nagino
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

Review 4.  Review of hepatopancreatoduodenectomy for biliary cancer: an extended radical approach of Japanese origin.

Authors:  Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Takashi Mizuno; Masato Nagino
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-01-27       Impact factor: 7.027

5.  Gallbladder cancer: an 'Indian' disease.

Authors:  V K Kapoor; A J McMichael
Journal:  Natl Med J India       Date:  2003 Jul-Aug       Impact factor: 0.537

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.